Grey Matters Health (AGNPF) Stock Price & Analysis

75 Followers

AGNPF Stock Chart & Stats

$0.24$0.00(0.00%)

At close: Nov 03 4:00 PM EST

Day’s Range: $0.24 - $0.24
52-Week Range: $0.22 - $0.67
Previous Close: $0.24
Volume: N/A
Average Volume (3M): 3,632
Market Cap: $2.11M
Enterprise Value: $3.70M
Total Cash (Recent Filing): $210.03K
Total Debt (Recent Filing): $0
Price to Earnings (P/E): ―
Beta: 0.62
Next Earnings: Dec 18, 2026 (Est.)
EPS Estimate: N/A
Next Dividend Ex-Date: N/A
Dividend Yield: N/A

Bulls Say, Bears Say

Bulls Say

Debt-free Balance Sheet

No debt reduces interest expense and near-term repayment pressure, preserving financial flexibility while the company develops its VR healthcare and wellness offerings. This provides a stronger base for funding operations than a similarly loss-making business carrying material leverage.

Narrowing Net Losses

The substantial reduction in annual net losses indicates progress toward better cost discipline, even though profitability remains negative. If this improvement continues, it could extend the company’s funding runway and reduce the scale of future financing required to reach commercial revenue.

Improving Cash Burn

Lower free-cash-flow burn is a constructive operating trend because it suggests the company is consuming capital more slowly than in prior periods. Continued improvement could make its VR healthcare development strategy more sustainable while reducing dependence on frequent external funding.

Bears Say

No Demonstrated Revenue Base

Zero reported revenue means the business has not yet demonstrated commercial traction or a repeatable monetization engine for its VR applications. Without revenue scale, future growth remains dependent on converting healthcare and wellness offerings into paying demand.

Persistent Negative Cash Flow

Persistent operating and free-cash-flow deficits show that the company is not self-funding its activities. Until revenue scale or materially lower expenses change that position, external capital is likely to remain important, limiting financial flexibility and increasing funding risk.

Ongoing Equity Pressure And Negative Returns

Negative returns on equity indicate that invested capital is not currently generating positive returns, while the pressured equity trend reflects ongoing value-erosion risk if losses persist. This weak capital efficiency can constrain the company’s ability to build durable shareholder value.

Grey Matters Health News

Algernon Health to Rebrand as Grey Matters Health and Enact 10-for-1 Share Consolidation

Algernon Pharmaceuticals ( ($TSE:AGN) ) just unveiled an update. Algernon Health Inc. will change its corporate name to Grey Matters Health Inc. and implement a ten-for-one consolidation of its Class

6M agoAGNPF AGW2

Psychedelic: Clearmind completes treatment, follow-up for CMND-100 trial

In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on treatment completion, a publication of study results and an analyst initiation. CLEARMIND

7M agoATAI CMND

Algernon Health to Rebrand as Grey Matters and Enact 10-for-1 Share Consolidation

Algernon Pharmaceuticals ( ($TSE:AGN) ) has provided an announcement. Algernon Health Inc. plans to change its corporate name to Grey Matters Health Inc., aligning its brand with an expanding focus

7M agoAGNPF AGW2

Algernon Health Rebrands U.S. Brain PET Network as NovaScan Neuroimaging Clinics

Algernon Pharmaceuticals ( ($TSE:AGN) ) has provided an update. Algernon Health has unveiled NovaScan Neuroimaging Clinics as the new brand and visual identity for its planned U.S. network of dedicated

7M agoAGNPF AGW2

Algernon to Launch First U.S. Brain-Dedicated PET Clinic in Florida as It Builds National Network

Algernon Pharmaceuticals ( ($TSE:AGN) ) has provided an update. Algernon Health will open its first brain-dedicated PET scanning clinic at the HCA Florida University Medical Office Building in Davie, on

7M agoAGNPF AGW2

Algernon Health Closes $857,001 Private Placement to Advance U.S. Alzheimer’s Clinic Plans

Algernon Pharmaceuticals ( ($TSE:AGN) ) just unveiled an announcement. Algernon Health has closed its non-brokered private placement financing at approximately CAD $857,001, following a fourth and final tranche that raised

10M agoAGNPF AGW2

Algernon Health Boosts Private Placement to $750,000 to Advance Alzheimer’s Imaging Clinics

Algernon Pharmaceuticals ( ($TSE:AGN) ) has shared an update. Algernon Health has upsized its non-brokered private placement financing to C$750,000 and closed a third tranche, raising C$352,500 from the sale

10M agoAGNPF AGW2

Algernon Health Secures CAD $210,000 in Private Placement to Boost Alzheimer’s Program

Algernon Pharmaceuticals ( ($TSE:AGN) ) just unveiled an update. Algernon Health Inc. announced the closing of the second tranche of its non-brokered private placement, raising CAD $210,000 from the sale

11M agoAGNPF AGW2

Algernon Pharmaceuticals Partners with AMI for U.S. Neuroimaging Clinics

Algernon Pharmaceuticals ( ($TSE:AGN) ) just unveiled an announcement. Algernon Pharmaceuticals has announced a strategic partnership with American Molecular Imaging (AMI) to enhance its planned U.S. neuroimaging clinics. This agreement

11M agoAGNPF AGW2

Algernon Health Closes First Tranche of Private Placement Financing

An announcement from Algernon Pharmaceuticals ( ($TSE:AGN) ) is now available. Algernon Health has successfully closed the first tranche of its non-brokered private placement, raising CAD $177,000. The funds will

11M agoAGNPF AGW2

Algernon Health Announces Private Placement and Share Structure Alteration

Algernon Pharmaceuticals ( ($TSE:AGN) ) just unveiled an announcement. Algernon Health Inc. has announced a non-brokered private placement to raise $500,000 through the issuance of units consisting of common shares

12M agoAGNPF AGW2

Algernon Pharmaceuticals announces $500,000 private placement

Algernon Health announced a non-brokered private placement for gross proceeds of $500,000 of units at an issue price of $0.07 per Unit. Each Unit will consist of one Class A

12M agoAGNPF AGW2

Psychedelic: Needham initiates coverage of atai, GH Research, MindMed

In this week’s “Psychedelic,” The Fly’s recurring series focused on psychedelic stock news, The Fly looks back on analyst initiations, a patent issuance and a company name change. NEEDHAM INITIATES

1y agoABBV ATAI

Algernon Pharmaceuticals completes name change to Algernon Health

Algernon Pharmaceuticals (AGNPF) completed its previously announced name change to Algernon Health. The Company’s common shares will begin trading under the new name on the CSE at market-open on Monday,

1y agoAGNPF AGW0

AGNPF FAQ

What was Grey Matters Health’s price range in the past 12 months?

Grey Matters Health lowest stock price was $0.22 and its highest was $0.67 in the past 12 months.

What is Grey Matters Health’s market cap?

Grey Matters Health’s market cap is $2.11M.

When is Grey Matters Health’s upcoming earnings report date?

The company’s upcoming earnings report date is not yet available.

How were Grey Matters Health’s earnings last quarter?

Grey Matters Health released its earnings results on Jul 29, 2026. The company reported -$0.093 earnings per share for the quarter.

Is Grey Matters Health overvalued?

Not enough analysts have published a price target to calculate whether the price is overvalued.

Does Grey Matters Health pay dividends?

Grey Matters Health does not currently pay dividends.

What is Grey Matters Health’s EPS estimate?

Grey Matters Health’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Grey Matters Health have?

Grey Matters Health has 8,923,237 shares outstanding.

What happened to Grey Matters Health’s price movement after its last earnings report?

Grey Matters Health reported an EPS of -$0.093 in its last earnings report. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of Grey Matters Health?

Currently, no hedge funds are holding shares in AGNPF

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Company Description